---
authors:
- Johari, Fatima
- Sklar, Kelsey
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/40531145/
file_path: 2025/06/fidaxomicin-vs-vancomycin-for-clostridioides-difficile-infec.md
issue: '6'
last_updated: '2025-07-30'
original_format: PubMed
pages: 493-494
patient_population: Adults
peer_reviewed: true
pmid: '40531145'
processed_date: '2025-07-30'
publication_date: '2025-06-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Fidaxomicin vs Vancomycin for Clostridioides difficile infection.
topics:
- Family Medicine
volume: '111'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '40531145'
  title: Fidaxomicin vs Vancomycin for Clostridioides difficile infection.
  authors:
  - last_name: Johari
    fore_name: Fatima
    initials: F
    affiliation: Northwell Health, Manhasset, New York.
  - last_name: Sklar
    fore_name: Kelsey
    initials: K
    affiliation: SUNY Downstate Health Sciences University, Brooklyn, New York, and
      NYC Health + Hospitals/Kings County, Brooklyn.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '111'
    issue: '6'
  publication_info:
    year: '2025'
    month: '06'
    full_date: '2025-06-01'
  article_ids: {}
  publication_types: *id001
related_articles:
- pmid: '40531145'
  title: Fidaxomicin vs Vancomycin for Clostridioides difficile infection.
  authors:
  - name: Johari F
    authtype: Author
    clusterid: ''
  - name: Sklar K
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2025 Jun
- pmid: '34017999'
  title: Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding
    and Environmental Contamination With Clostridioides difficile.
  authors:
  - name: Turner NA
    authtype: Author
    clusterid: ''
  - name: Warren BG
    authtype: Author
    clusterid: ''
  - name: Gergen-Teague MF
    authtype: Author
    clusterid: ''
  - name: Addison RM
    authtype: Author
    clusterid: ''
  - name: Addison B
    authtype: Author
    clusterid: ''
  - name: Rutala WA
    authtype: Author
    clusterid: ''
  - name: Weber DJ
    authtype: Author
    clusterid: ''
  - name: Sexton DJ
    authtype: Author
    clusterid: ''
  - name: Anderson DJ
    authtype: Author
    clusterid: ''
  source: Clin Infect Dis
  pubdate: 2022 Mar 1
- pmid: '39355263'
  title: 'A Retrospective Assessment of Guideline Adherence and Treatment Outcomes
    From Clostridioides difficile Infection Following the IDSA 2021 Clinical Guideline
    Update: Clostridioides difficile Infection.'
  authors:
  - name: Dubberke ER
    authtype: Author
    clusterid: ''
  - name: Li Q
    authtype: Author
    clusterid: ''
  - name: Obi EN
    authtype: Author
    clusterid: ''
  - name: Turzhitsky V
    authtype: Author
    clusterid: ''
  - name: Siddiqui F
    authtype: Author
    clusterid: ''
  - name: Nathanson BH
    authtype: Author
    clusterid: ''
  source: Open Forum Infect Dis
  pubdate: 2024 Oct
- pmid: '31773143'
  title: 'Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents
    with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter,
    Randomized, Single-blind Clinical Trial (SUNSHINE).'
  authors:
  - name: Wolf J
    authtype: Author
    clusterid: ''
  - name: Kalocsai K
    authtype: Author
    clusterid: ''
  - name: Fortuny C
    authtype: Author
    clusterid: ''
  - name: Lazar S
    authtype: Author
    clusterid: ''
  - name: Bosis S
    authtype: Author
    clusterid: ''
  - name: Korczowski B
    authtype: Author
    clusterid: ''
  - name: Petit A
    authtype: Author
    clusterid: ''
  - name: Bradford D
    authtype: Author
    clusterid: ''
  - name: Croos-Dabrera R
    authtype: Author
    clusterid: ''
  - name: Incera E
    authtype: Author
    clusterid: ''
  - name: Melis J
    authtype: Author
    clusterid: ''
  - name: van Maanen R
    authtype: Author
    clusterid: ''
  source: Clin Infect Dis
  pubdate: 2020 Dec 17
- pmid: '40326081'
  title: Partial Courses of Fidaxomicin Followed by Oral Vancomycin and the Effect
    on Recurrence of Clostridioides difficile Infections.
  authors:
  - name: Papamanolis IC
    authtype: Author
    clusterid: ''
  - name: Stornelli N
    authtype: Author
    clusterid: ''
  - name: Everson N
    authtype: Author
    clusterid: ''
  - name: Ahmad Z
    authtype: Author
    clusterid: ''
  - name: Kamrada M
    authtype: Author
    clusterid: ''
  - name: Lockhart ER
    authtype: Author
    clusterid: ''
  - name: McDaniel L
    authtype: Author
    clusterid: ''
  source: Ann Pharmacother
  pubdate: 2025 May 6
---

# Fidaxomicin vs Vancomycin for Clostridioides difficile infection.

**Authors:** Johari, Fatima, Sklar, Kelsey

**Published in:** American family physician | Vol. 111, No. 6 | 2025-06-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/40531145/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/40531145/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
